Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 130

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Probiotic supplement attenuates chemotherapy-related cognitive impairment in patients with breast cancer: a randomised, double-blind, and placebo-controlled trial

Juan, Zhang, Chen, Jie, Ding, Boni, Yongping, Liang, Liu, Kai, Wang, Ling, Le, Yuan, Liao, Qin, Shi, Jingcheng, Huang, Jufang, Wu, Yuhui, Ma, Daqing, Ouyang, Wen, Tong, Jianbin·2022·European Journal of Cancer
DOI 10.1016/j.ejca.2021.11.006
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ejca.2021.11.006

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Research works printed but not linked: 49

  1. Ouimet, 2009, Measuring neuropsychological change following breast cancer treatment: an analysis of statistical models, J Clin Exp Neuropsychol, 31, 73, 10.1080/13803390801992725 · DOI
  2. Ahles, 2008, Cognitive function in breast cancer patients prior to adjuvant treatment, Breast Cancer Res Treat, 110, 143, 10.1007/s10549-007-9686-5 · DOI
  3. Janelsins, 2014, Prevalence, mechanisms, and management of cancer-related cognitive impairment, Int Rev Psychiatr, 26, 102, 10.3109/09540261.2013.864260 · DOI
  4. Jansen, 2011, A prospective longitudinal study of chemotherapy-induced cognitive changes in breast cancer patients, Support Care Cancer, 19, 1647
  5. Wefel, 2010, Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer, Cancer, 116, 3348, 10.1002/cncr.25098 · DOI
  6. Wefel, 2015, Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adults, CA Cancer J Clin, 65, 123
  7. Boykoff, 2009, Confronting chemobrain: an in-depth look at survivors' reports of impact on work, social networks, and health care response, J Cancer Surviv, 3, 223, 10.1007/s11764-009-0098-x · DOI
  8. Wefel, 2004, The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial, Cancer, 100, 2292, 10.1002/cncr.20272 · DOI
  9. Tannock, 2004, Cognitive impairment associated with chemotherapy for cancer: report of a workshop, J Clin Oncol, 22, 2233, 10.1200/JCO.2004.08.094 · DOI
  10. Cherrier, 2013, A randomized trial of cognitive rehabilitation in cancer survivors, Life Sci, 93, 617, 10.1016/j.lfs.2013.08.011 · DOI
  11. Galantino, 2012, Longitudinal impact of yoga on chemotherapy-related cognitive impairment and quality of life in women with early stage breast cancer: a case series, Explore (NY), 8, 127, 10.1016/j.explore.2011.12.001 · DOI
  12. Alvarez, 2013, The effect of EEG biofeedback on reducing postcancer cognitive impairment, Integr Cancer Ther, 12, 475, 10.1177/1534735413477192 · DOI
  13. Zeng, 2018, Effects of acupuncture on cancer-related cognitive impairment in Chinese gynecological cancer patients: a pilot cohort study, Integr Cancer Ther, 17, 737, 10.1177/1534735418777109 · DOI
  14. Janelsins, 2016, YOCAS(c)(R) yoga reduces self-reported memory difficulty in cancer survivors in a nationwide randomized clinical trial: investigating relationships between memory and sleep, Integr Cancer Ther, 15, 263, 10.1177/1534735415617021 · DOI
  15. Fung, 2017, Interactions between the microbiota, immune and nervous systems in health and disease, Nat Neurosci, 20, 145, 10.1038/nn.4476 · DOI · Paper page
  16. Wang, 2021, Perioperative probiotic treatment decreased the incidence of postoperative cognitive impairment in elderly patients following non-cardiac surgery: a randomised double-blind and placebo-controlled trial, Clin Nutr, 40, 64, 10.1016/j.clnu.2020.05.001 · DOI
  17. Loman, 2019, Chemotherapy-induced neuroinflammation is associated with disrupted colonic and bacterial homeostasis in female mice, Sci Rep, 9, 16490, 10.1038/s41598-019-52893-0 · DOI
  18. Conn, 1977, Trailmaking and number-connection tests in the assessment of mental state in portal systemic encephalopathy, Am J Dig Dis, 22, 541, 10.1007/BF01072510 · DOI
  19. Tam, 2013, The role of processing speed in the Brief Visuospatial Memory Test - revised, Clin Neuropsychol, 27, 962, 10.1080/13854046.2013.797500 · DOI
  20. Zung, 1971, A rating instrument for anxiety disorders, Psychosomatics, 12, 371, 10.1016/S0033-3182(71)71479-0 · DOI · Paper page
  21. Lacritz, 1998, The Hopkins verbal learning test and CVLT: a preliminary comparison, Arch Clin Neuropsychol, 13, 623
  22. Amodio, 1999, Clinical features and survivial of cirrhotic patients with subclinical cognitive alterations detected by the number connection test and computerized psychometric tests, Hepatology, 29, 1662, 10.1002/hep.510290619 · DOI
  23. Leung, 2011, The use of the Digit Span Test in screening for cognitive impairment in acute medical inpatients, Int Psychogeriatr, 23, 1569, 10.1017/S1041610211000792 · DOI
  24. Sutin, 2019, Verbal fluency and risk of dementia, Int J Geriatr Psychiatr, 34, 863, 10.1002/gps.5081 · DOI
  25. Janelsins, 2017, Cognitive complaints in survivors of breast cancer after chemotherapy compared with age-matched controls: an analysis from a nationwide, multicenter, prospective longitudinal study, J Clin Oncol, 35, 506, 10.1200/JCO.2016.68.5826 · DOI
  26. Wagner, 2020, Patient-reported cognitive impairment among women with early breast cancer randomly assigned to endocrine therapy alone versus chemoendocrine therapy: results from TAILORx, J Clin Oncol, 38, 1875, 10.1200/JCO.19.01866 · DOI
  27. Arevalo, 2015, The neuroprotective actions of oestradiol and oestrogen receptors, Nat Rev Neurosci, 16, 17, 10.1038/nrn3856 · DOI
  28. Bhatia, 2008, Fragrance material review on p-mentha-1,8-dien-7-ol, Food Chem Toxicol, 46, S197, 10.1016/j.fct.2008.06.071 · DOI
  29. Chen, 2018, Intranasal perillyl alcohol for glioma therapy: molecular mechanisms and clinical development, Int J Mol Sci, 19, 10.3390/ijms19123905 · DOI
  30. Gomes, 2017, Perillyl alcohol, a pleiotropic natural compound suitable for brain tumour therapy, targets free radicals, Arch Immunol Ther Exp (Warsz)., 65, 285, 10.1007/s00005-017-0459-5 · DOI
  31. Bernstein, 2018, A brief psychoeducational intervention improves memory contentment in breast cancer survivors with cognitive concerns: results of a single-arm prospective study, Support Care Cancer, 26, 2851
  32. Winters-Stone, 2018, The effects of resistance exercise on biomarkers of breast cancer prognosis: a pooled analysis of three randomized trials, Cancer Epidemiol Biomarkers Prev, 27, 146, 10.1158/1055-9965.EPI-17-0766 · DOI
  33. Pusztai, 2004, Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy, Cytokine, 25, 94, 10.1016/j.cyto.2003.10.004 · DOI
  34. Shibayama, 2014, Association between adjuvant regional radiotherapy and cognitive function in breast cancer patients treated with conservation therapy, Cancer Med, 3, 702, 10.1002/cam4.174 · DOI
  35. Aluise, 2011, 2-Mercaptoethane sulfonate prevents doxorubicin-induced plasma protein oxidation and TNF-α release: implications for the reactive oxygen species-mediated mechanisms of chemobrain, Free Radic Biol Med, 50, 1630, 10.1016/j.freeradbiomed.2011.03.009 · DOI
  36. Khan, 2016, Early manifestation of mild cognitive impairment in B-cell non-Hodgkin's lymphoma patients receiving CHOP and rituximab-CHOP chemotherapy, Naunyn-Schmiedeberg’s Arch Pharmacol, 389, 1253, 10.1007/s00210-016-1290-y · DOI
  37. Anis, 2018, Evaluation of phytomedicinal potential of perillyl alcohol in an in vitro Parkinson's Disease model, Drug Dev Res, 79, 218, 10.1002/ddr.21436 · DOI
  38. Kim, 2013, Association of age-related changes in circulating intermediary lipid metabolites, inflammatory and oxidative stress markers, and arterial stiffness in middle-aged men, Age (Dordr), 35, 1507, 10.1007/s11357-012-9454-2 · DOI
  39. Popik, 2015, 1-aminocyclopropanecarboxylic acid (ACPC) produces procognitive but not antipsychotic-like effects in rats, Psychopharmacology (Berl), 232, 1025, 10.1007/s00213-014-3738-4 · DOI
  40. Alonso-Gutierrez, 2013, Metabolic engineering of Escherichia coli for limonene and perillyl alcohol production, Metab Eng, 19, 33, 10.1016/j.ymben.2013.05.004 · DOI
  41. Jongedijk, 2016, Biotechnological production of limonene in microorganisms, Appl Microbiol Biotechnol, 100, 2927, 10.1007/s00253-016-7337-7 · DOI
  42. Xu, 2018, Discovery and characterization of 1-Aminocyclopropane-1-carboxylic acid synthase of bacterial origin, J Am Chem Soc, 140, 16957, 10.1021/jacs.8b11463 · DOI
  43. Koekkoek, 2015, Cognitive function in patients with diabetes mellitus: guidance for daily care, Lancet Neurol, 14, 329, 10.1016/S1474-4422(14)70249-2 · DOI
  44. McCrimmon, 2012, Diabetes and cognitive dysfunction, Lancet, 379, 2291, 10.1016/S0140-6736(12)60360-2 · DOI
  45. Balõtšev, 2017, Inflammatory, cardio-metabolic and diabetic profiling of chronic schizophrenia, Eur Psychiatr, 39, 1, 10.1016/j.eurpsy.2016.05.010 · DOI
  46. Ioannidis, 2018, The challenge of reforming nutritional epidemiologic Research, Jama, 320, 969, 10.1001/jama.2018.11025 · DOI
  47. Ahles, 2014, Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: the impact of APOE and smoking, Psycho Oncol, 23, 1382, 10.1002/pon.3545 · DOI
  48. Koleck, 2017, An exploratory study of host polymorphisms in genes that clinically characterize breast cancer tumours and pretreatment cognitive performance in breast cancer survivors, Breast Cancer (Dove Med Press), 9, 95
  49. Small, 2011, Catechol-O-methyltransferase genotype modulates cancer treatment-related cognitive deficits in breast cancer survivors, Cancer, 117, 1369, 10.1002/cncr.25685 · DOI

Cited by

Metadata

Authors
Juan, Z., Chen, J., Ding, B., Yongping, L., Liu, K., Wang, L., Le, Y., Liao, Q., Shi, J., Huang, J., Wu, Y., Ma, D., Ouyang, W., & Tong, J.
Venue
European Journal of Cancer
Publisher
Elsevier BV
Published
2022-01
Volume
161
Pages
10-22
ISSN
0959-8049
DOI
10.1016/j.ejca.2021.11.006
Cited by
130
References
6
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.